drugset / Trial / NCT04019652

The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers

NCT04019652

Phase 1 Completed 55 enrolled Daiichi Sankyo
RandomizedCrossoverDouble-blindPrevention

Summary

This study will test if a study drug (CS-3150) will affect the heart rate in healthy males and females. Two doses of the study drug will be tested. Heart rate is not expected to be different between the study groups.

Timeline

Start
2015-11-19
Primary completion
2015-12-23
Completion
2015-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject CS-3150 Unknown 10 mg Oral
Subject CS-3150 Unknown 40 mg Oral
Subject Moxifloxacin Small molecule 400 mg Oral

Indications